135 related articles for article (PubMed ID: 21518024)
1. Circulating LL-37 is a biomarker for eczema severity in children.
Leung TF; Ching KW; Kong AP; Wong GW; Chan JC; Hon KL
J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):518-22. PubMed ID: 21518024
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema.
Ballardini N; Johansson C; Lilja G; Lindh M; Linde Y; Scheynius A; Agerberth B
Br J Dermatol; 2009 Jul; 161(1):40-7. PubMed ID: 19309368
[TBL] [Abstract][Full Text] [Related]
3. Cathelicidin deficiency predisposes to eczema herpeticum.
Howell MD; Wollenberg A; Gallo RL; Flaig M; Streib JE; Wong C; Pavicic T; Boguniewicz M; Leung DY
J Allergy Clin Immunol; 2006 Apr; 117(4):836-41. PubMed ID: 16630942
[TBL] [Abstract][Full Text] [Related]
4. Age, sex, and disease status as determinants of skin hydration and transepidermal water loss among children with and without eczema.
Hon KL; Lam PH; Ng WG; Kung JS; Cheng NS; Lin ZX; Chow CM; Leung TF
Hong Kong Med J; 2020 Feb; 26(1):19-26. PubMed ID: 32051333
[TBL] [Abstract][Full Text] [Related]
5. Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells from atopic eczema patients and healthy individuals.
Agerberth B; Buentke E; Bergman P; Eshaghi H; Gabrielsson S; Gudmundsson GH; Scheynius A
Allergy; 2006 Apr; 61(4):422-30. PubMed ID: 16512803
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease.
Uysal P; Simsek G; Durmus S; Sozer V; Aksan H; Yurt S; Cuhadaroglu C; Kosar F; Gelisgen R; Uzun H
Int J Chron Obstruct Pulmon Dis; 2019; 14():321-330. PubMed ID: 30774329
[TBL] [Abstract][Full Text] [Related]
7. Cathelicidin (LL-37) and its correlation with pro-oxidant, antioxidant balance and disease activity in systemic lupus erythematosus: a cross-sectional human study.
Sahebari M; Roshandel G; Saadati N; Saghafi M; Abdolahi N; Rezaieyazdi Z
Lupus; 2017 Aug; 26(9):975-982. PubMed ID: 28420069
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of peptide cathelicidin LL-37 in elderly patients with depression.
Kozłowska E; Wysokiński A; Brzezińska-Błaszczyk E
Psychiatry Res; 2017 Sep; 255():156-160. PubMed ID: 28550757
[TBL] [Abstract][Full Text] [Related]
9. Body composition does not affect serum levels of cathelicidin LL-37 in elderly women with unipolar depression.
Szczepocka E; Kozłowska E; Brzezińska-Błaszczyk E; Wysokiński A
Nord J Psychiatry; 2018 Jan; 72(1):45-50. PubMed ID: 28959904
[TBL] [Abstract][Full Text] [Related]
10. Do we need another symptom score for childhood eczema?
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Cheng NS; Leung TF
J Dermatolog Treat; 2018 Aug; 29(5):510-514. PubMed ID: 28849683
[TBL] [Abstract][Full Text] [Related]
11. Are skin equipment for assessing childhood eczema any good?
Hon KL; Kung JSC; Ng WG; Tsang KYC; Cheng N; Leung TF
J Dermatolog Treat; 2021 Feb; 32(1):45-48. PubMed ID: 29460656
[TBL] [Abstract][Full Text] [Related]
12. The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure.
Zhou Q; Pan LL; Xue R; Ni G; Duan Y; Bai Y; Shi C; Ren Z; Wu C; Li G; Agerberth B; Sluijter JP; Sun J; Xiao J
Theranostics; 2020; 10(14):6167-6181. PubMed ID: 32483446
[No Abstract] [Full Text] [Related]
13. Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?
Hizal M; Bruni C; Romano E; Mazzotta C; Guiducci S; Bellando Randone S; Blagojevic J; Lepri G; Tufan A; Matucci Cerinic M
Clin Rheumatol; 2015 Apr; 34(4):795-8. PubMed ID: 25597616
[TBL] [Abstract][Full Text] [Related]
14. Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
Ong PY; Ohtake T; Brandt C; Strickland I; Boguniewicz M; Ganz T; Gallo RL; Leung DY
N Engl J Med; 2002 Oct; 347(15):1151-60. PubMed ID: 12374875
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.
Luan JJ; Xing GQ
J Nephrol; 2017 Feb; 30(1):63-71. PubMed ID: 27476166
[TBL] [Abstract][Full Text] [Related]
16. Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.
Majewski K; Żelechowska P; Brzezińska-Błaszczyk E
Clin Invest Med; 2017 Feb; 40(1):E34-E39. PubMed ID: 28218580
[TBL] [Abstract][Full Text] [Related]
17. The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.
Babikir IH; Abugroun EA; Bilal NE; Alghasham AA; Abdalla EE; Adam I
BMC Infect Dis; 2018 Jan; 18(1):17. PubMed ID: 29310594
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial.
Hon KL; Tsang YC; Lee VW; Pong NH; Ha G; Lee ST; Chow CM; Leung TF
J Dermatolog Treat; 2016; 27(2):156-62. PubMed ID: 26270469
[TBL] [Abstract][Full Text] [Related]
19. Circulating cathelicidin LL-37 level is increased in euthymic patients with bipolar disorder.
Kozłowska E; Żelechowska P; Brzezińska-Błaszczyk E; Margulska A; Wysokiński A
J Clin Neurosci; 2018 Feb; 48():168-172. PubMed ID: 29239826
[TBL] [Abstract][Full Text] [Related]
20. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
Tjabringa GS; Rabe KF; Hiemstra PS
Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
